Provides strategic and tactical direction to the business development function by evaluating new initiatives and business opportunities for the Employment Services Group.  Identified ten new niche markets for esoteric drug testing. Conducts feasibility studies to determine potential entry strategy into expansion markets. Helped support growth in two new markets, exceeding budget by 50%, improving margin by over 20%.  Collaborates with marketing to provide sales support materials.  Determines marketing and branding strategies.    Establishes business development strategies and prepares plans to implement strategies.  Advises management of the financial, organizational and capital resource implications of new business opportunities
Senior Vice President and General Manager (Sept 2000 to January 2005)
Northwest Toxicology (NWT), Salt Lake City, UT
Executive and P&L responsibility for Northwest Toxicology (NWTox), a division of a privately held business providing drug testing and sophisticated bioanalytical services for industrial clients and pharmaceutical manufacturers.  Turned around unprofitable business unit (-1% to 20% Operating Margin) by diversifying service menu, increasing revenue and decreasing costs.  Increased revenue by over 30% and average transaction price by almost 50%.  Established 10 % market share in a niche within 2 years, while establishing presence in two additional markets. Positioned NWTox for acquisition by LabOne.   Responsibilit y included NWTox laboratory leadership and operations, strategic planning and tactical execution, business development, technical and quality assurance oversight, regulatory compliance, financial and sales/marketing accountability, client service, logistics, staffing, training, and legal support.  Consultant to DHHS and DOT in matters regarding drug testing. Served on Federal Advisory Committee on Electronic Data Handling, Storage and Transmission for the DOT in 2003-4. 
Director, Forensic Toxicology (May 1993 to Aug 2000)
CHW, Quest Diagnostics, Inc., Leesburg, FL and Atlanta, GA
Oversee operations for two SAMHSA/DOT/NRC/AHCA drug testing laboratories.  Responsible for testing production, records, department financials, licensing, procedures, QA/QC, staffing, training, client services, legal support, expert testimony, and technical consultation. 

Deputy Director
Sports Testing Center (Summer 1996)
SmithKline Beecham Clinical Laboratories

Oversee specimen processing and technical activities for athletic drug testing services provided to the International Olympic Committee during the 1996 Centennial Summer Olympic Games and the Para-Olympic Games.

Marketing Manager, Automated Drug
Testing Systems, 1991 - 1993
Roche Diagnostic Systems, Inc.
Branchburg, New Jersey
Responsibilities included all aspects of product marketing.
Director, Department of Toxicology
1987 - 1991
Roche Biomedical Laboratories
Raritan, New Jersey
This department included both N.I.D.A. and C.A.P./F.U.D.T. accredited forensic drug testing and therapeutic drug monitoring sections.  Responsibilities included:  all operations:  specimen handling, chain of custody, technical methodology and development, operating procedures, data preparation, personnel and budget management, staff training, litigation preparation, legal testimony, and client consultations.

POST DOCTORAL POSITIONS

BRITISH SPORTS COUNCIL POST-DOCTORAL RESEARCH FELLOWSHIP (1985-1987)
Drug Control and Teach Center (International Olympic Committee accredited laboratory) Kings College, University of London
This project set out to establish a routine screen for beta adrenergic receptor blocking drugs.  Since athletes requiring high precision, i.e., pistol and rifle shooters, pentathlon competitors, archers, etc., are know to use beta-blockers to reduce tremor, use of these drugs have been banned from international competition.  The only reliable method of detection, then employed GC